Literature DB >> 20592251

Toll-like receptor control of glucocorticoid-induced apoptosis in human plasmacytoid predendritic cells (pDCs).

Yves Lepelletier1, Raphaël Zollinger, Cristina Ghirelli, Françoise Raynaud, Réda Hadj-Slimane, Antonio Cappuccio, Olivier Hermine, Yong-Jun Liu, Vassili Soumelis.   

Abstract

Microbial infection triggers the endogenous production of immunosuppressive glucocorticoid (GC) hormones and simultaneously activates innate immunity through toll-like receptors (TLRs). How innate immune cells integrate these 2 opposing signals in dictating immunity or tolerance to infection is not known. In this study, we show that human plasmacytoid predendritic cells (pDCs) were highly sensitive to GC-induced apoptosis. Strikingly, they were protected by microbial stimulation through TLR-7 and TLR-9, but not by microbial-independent stimuli, such as interleukin-3, granulocyte macrophage colony-stimulating factor, or CD40-ligand. This protection was dependent on TLR-induced autocrine tumor necrosis factor-α and interferon-α, which collectively increased the expression ratio between antiapoptotic genes (Bcl-2, Bcl-xL, BIRC3, CFLAR) versus proapoptotic genes (Caspase-8, BID, BAD, BAX). In particular, virus-induced Bcl-2 up-regulation was dependent on autocrine interferon-α. Using small interfering RNA technology, we demonstrated that Bcl-2 and CFLAR/c-flip were essential for TLR-induced protection of pDCs from GC-induced caspase-8-mediated apoptosis. Our results demonstrate a novel property of the TLR pathway in regulating the interface between GC and innate immunity and reveal a previously undescribed mechanism of GC resistance.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20592251     DOI: 10.1182/blood-2010-05-282913

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  26 in total

1.  Etomidate increases susceptibility to pneumonia in trauma patients.

Authors:  Karim Asehnoune; Pierre Joachim Mahe; Philippe Seguin; Samir Jaber; Boris Jung; Christophe Guitton; Nolwen Chatel-Josse; Aurelie Subileau; Anne Charlotte Tellier; Françoise Masson; Benoit Renard; Yannick Malledant; Corinne Lejus; Christelle Volteau; Véronique Sébille; Antoine Roquilly
Journal:  Intensive Care Med       Date:  2012-07-10       Impact factor: 17.440

Review 2.  Minireview: Glucocorticoids in autoimmunity: unexpected targets and mechanisms.

Authors:  Jamie R Flammer; Inez Rogatsky
Journal:  Mol Endocrinol       Date:  2011-04-21

Review 3.  dsRNA sensors and plasmacytoid dendritic cells in host defense and autoimmunity.

Authors:  Yaming Wang; Melissa Swiecki; Stephen A McCartney; Marco Colonna
Journal:  Immunol Rev       Date:  2011-09       Impact factor: 12.988

4.  A nonredundant role for plasmacytoid dendritic cells in host defense against the human fungal pathogen Aspergillus fumigatus.

Authors:  Zaida G Ramirez-Ortiz; Chrono K Lee; Jennifer P Wang; Louis Boon; Charles A Specht; Stuart M Levitz
Journal:  Cell Host Microbe       Date:  2011-05-19       Impact factor: 21.023

Review 5.  Glucocorticoid receptor modulates dendritic cell function in ulcerative colitis.

Authors:  Xinxin Yang; Jingshu Geng; Hongxue Meng
Journal:  Histol Histopathol       Date:  2020-07-24       Impact factor: 2.303

6.  Possible involvement of toll-like receptors in the pathogenesis of myasthenia gravis.

Authors:  Yu-Zhong Wang; Mei Yan; Fa-Fa Tian; Jun-Mei Zhang; Qun Liu; Huan Yang; Wen-Bin Zhou; Jing Li
Journal:  Inflammation       Date:  2013-02       Impact factor: 4.092

Review 7.  The role of dendritic cells in autoimmunity.

Authors:  Dipyaman Ganguly; Stefan Haak; Vanja Sisirak; Boris Reizis
Journal:  Nat Rev Immunol       Date:  2013-07-05       Impact factor: 53.106

Review 8.  Plasmacytoid dendritic cells: recent progress and open questions.

Authors:  Boris Reizis; Anna Bunin; Hiyaa S Ghosh; Kanako L Lewis; Vanja Sisirak
Journal:  Annu Rev Immunol       Date:  2011       Impact factor: 28.527

Review 9.  Harnessing cancer immunotherapy during the unexploited immediate perioperative period.

Authors:  Pini Matzner; Elad Sandbank; Elad Neeman; Oded Zmora; Vijaya Gottumukkala; Shamgar Ben-Eliyahu
Journal:  Nat Rev Clin Oncol       Date:  2020-02-17       Impact factor: 66.675

10.  A CD2 high-expressing stress-resistant human plasmacytoid dendritic-cell subset.

Authors:  Christian Bryant; Phillip D Fromm; Fiona Kupresanin; Georgina Clark; Kenneth Lee; Candice Clarke; Pablo A Silveira; Hayley Suen; Ross Brown; Elizabeth Newman; Ilona Cunningham; P Joy Ho; John Gibson; Kenneth Bradstock; Douglas Joshua; Derek Nj Hart
Journal:  Immunol Cell Biol       Date:  2016-01-21       Impact factor: 5.126

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.